{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T15:37:09Z","timestamp":1787240229900,"version":"build-2736575974"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2000,12,1]],"date-time":"2000-12-01T00:00:00Z","timestamp":975628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2000,12,1]],"date-time":"2000-12-01T00:00:00Z","timestamp":975628800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Leukemia"],"published-print":{"date-parts":[[2000,12,1]]},"DOI":"10.1038\/sj.leu.2401938","type":"journal-article","created":{"date-parts":[[2002,9,4]],"date-time":"2002-09-04T14:28:09Z","timestamp":1031149689000},"page":"2286-2294","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":156,"title":["Long-term results of Total Therapy studies 11, 12 and 13A for childhood acute lymphoblastic leukemia at St Jude Children's Research Hospital"],"prefix":"10.1038","volume":"14","author":[{"given":"C-H","family":"Pui","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JM","family":"Boyett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"GK","family":"Rivera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"ML","family":"Hancock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JT","family":"Sandlund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"RC","family":"Ribeiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JE","family":"Rubnitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"FG","family":"Behm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"SC","family":"Raimondi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Gajjar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B","family":"Razzouk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"Campana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"LE","family":"Kun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MV","family":"Relling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"WE","family":"Evans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2000,12,20]]},"reference":[{"key":"BF2401938_CR1","first-page":"150","volume":"6","author":"C-H Pui","year":"1992","unstructured":"Pui C-H, Simone JV, Hancock ML, Evans WE, Williams DL, Bowman WP, Dahl GV, Dodge RK, Ochs J, Abromowitch, Rivera GK . Impact of three methods of treatment intensification on acute lymphoblastic leukemia in children: long-term results of St Jude Therapy Study X Leukemia 1992 6: 150\u2013157","journal-title":"Leukemia"},{"key":"BF2401938_CR2","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1056\/NEJM199310283291801","volume":"329","author":"G Rivera","year":"1993","unstructured":"Rivera G, Pinkel D, Simone JV, Hancock ML, Crist WM . Treatment of acute lymphoblastic leukemia. 30 years\u2019 experience at St Jude Children's Research Hospital New Engl J Med 1993 329: 1289\u20131295","journal-title":"New Engl J Med"},{"key":"BF2401938_CR3","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/0140-6736(91)90733-6","volume":"337","author":"GK Rivera","year":"1991","unstructured":"Rivera GK, Raimondi SC, Hancock ML, Behm FG, Pui C-H, Abromowitch M, Mirro J Jr, Ochs JS, Look AT, Williams DL, Murphy SB, Dahl GV, Kalwinshy DK, Evans WE, Kun LE, Simone JV, Crist WM . Improved outcome in childhood acute lymphoblastic leukaemia with reinforced early treatment and rotational combination chemotherapy Lancet 1991 337: 61\u201366","journal-title":"Lancet"},{"key":"BF2401938_CR4","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1056\/NEJM199802193380803","volume":"338","author":"WE Evans","year":"1998","unstructured":"Evans WE, Relling MV, Rodman JH, Crom WR, Boyett JM, Pui C-H . Conventional compared with individualized chemotherapy for childhood acute lymphoblastic leukemia New Engl J Med 1998 338: 499\u2013505","journal-title":"New Engl J Med"},{"key":"BF2401938_CR5","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1182\/blood.V92.2.411","volume":"92","author":"C-H Pui","year":"1998","unstructured":"Pui C-H, Mahmoud HH, Rivera GK, Hancock ML, Sandlund JT, Behm FG, Head DR, Relling MV, Ribeiro RC, Rubnitz JE, Kun LE, Evans WE . Early intensification of intrathecal chemotherapy virtually eliminates central nervous system relapse in children with acute lymphoblastic leukemia Blood 1998 92: 411\u2013415","journal-title":"Blood"},{"key":"BF2401938_CR6","doi-asserted-by":"publisher","first-page":"1682","DOI":"10.1056\/NEJM199112123252402","volume":"325","author":"C-H Pui","year":"1991","unstructured":"Pui C-H, Ribeiro RC, Hancock ML, Rivera GK, Evans WE, Raimondi SC, Head DR, Behm FG, Mahmoud HM, Sandlund JT, Crist WM . Acute myeloid leukemia in children treated with epipodophyllotoxins for acute lymphoblastic leukemia New Engl J Med 1991 325: 1682\u20131687","journal-title":"New Engl J Med"},{"key":"BF2401938_CR7","doi-asserted-by":"publisher","first-page":"1996","DOI":"10.1172\/JCI117552","volume":"94","author":"TW Synold","year":"1994","unstructured":"Synold TW, Relling MV, Boyett JM, Rivera GK, Sandlund JT, Mahmoud H, Crist WM, Pui C-H, Evans WE . Blast cell methotrexate-polyglutamate accumulation in vivo differs by lineage, ploidy, and methotrexate dose in acute lymphoblastic leukemia J Clin Invest 1994 94: 1996\u20132001","journal-title":"J Clin Invest"},{"key":"BF2401938_CR8","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1182\/blood.V84.2.564.564","volume":"84","author":"JC Barredo","year":"1994","unstructured":"Barredo JC, Synold TW, Laver J, Relling MV, Pui C-H, Priest DG, Evans WE . Differences in constitutive and post-methotrexate folylpolyglutamate synthetase activity in B-lineage and T-lineage leukemia Blood 1994 84: 564\u2013569","journal-title":"Blood"},{"key":"BF2401938_CR9","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1124\/mol.52.1.155","volume":"52","author":"AJ Galpin","year":"1997","unstructured":"Galpin AJ, Schuetz JD, Masson E, Yanishevski Y, Synold TW, Barredo JC, Pui C-H, Relling MV, Evans WE . Differences in folylpolyglutamate synthetase and dihydrofolate reductase expression in human B-lineage versus T-lineage leukemic lymphoblasts: mechanisms for lineage differences in methotrexate polyglutamylation and cytotoxicity Mol Pharmacol 1997 52: 155\u2013163","journal-title":"Mol Pharmacol"},{"key":"BF2401938_CR10","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1182\/blood.V82.2.343.343","volume":"82","author":"C-H Pui","year":"1993","unstructured":"Pui C-H, Behm FG, Crist WM . Clinical and biologic relevance of immunologic marker studies in childhood acute lymphoblastic leukemia Blood 1993 82: 343\u2013362","journal-title":"Blood"},{"key":"BF2401938_CR11","volume-title":"Mitelman F (ed). An International System for Human Cytogenetic Nomeclature","author":"1995 ISCN","year":"1995","unstructured":"ISCN 1995 . Mitelman F (ed). An International System for Human Cytogenetic Nomeclature Karger: Basel 1995"},{"key":"BF2401938_CR12","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1038\/sj.leu.2400749","volume":"11","author":"RC Ribeiro","year":"1997","unstructured":"Ribeiro RC, Broniscer A, Rivera GK, Hancock ML, Raimondi SC, Sandlund JT, Crist W, Pui C-H . Philadelphia chromosome-positive acute lymphoblastic leukemia in children: durable responses to chemotherapy associated with low initial white blood cell counts Leukemia 1997 11: 1493\u20131496","journal-title":"Leukemia"},{"key":"BF2401938_CR13","first-page":"163","volume":"50","author":"N Mantel","year":"1966","unstructured":"Mantel N . Evaluation of survival data and two new rank order statistics arising in its consideration Cancer Chemother Rep 1966 50: 163\u2013170","journal-title":"Cancer Chemother Rep"},{"key":"BF2401938_CR14","unstructured":"Kalbfleisch JD, Prentice RL . The Statistical Analysis of Failure Time Data John Wiley: New York 1980 pp 163\u2013188"},{"key":"BF2401938_CR15","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1214\/aos\/1176350951","volume":"16","author":"RJ Gray","year":"1988","unstructured":"Gray RJ . A class of K-sample tests for comparing the cumulative incidence of a competing risk Ann Stat 1988 16: 1141\u20131154","journal-title":"Ann Stat"},{"key":"BF2401938_CR16","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1038\/sj.leu.2401818","volume":"14","author":"W Leung","year":"2000","unstructured":"Leung W, Hudson M, Zhu Y, Rivera GK, Ribeiro RC, Sandlund JT, Bowman LC, Evans WE, Kun L, Pui C-H . Late effects in survivors of infant leukemia Leukemia 2000 14: 1185\u20131190","journal-title":"Leukemia"},{"key":"BF2401938_CR17","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1200\/JCO.1996.14.1.18","volume":"14","author":"M Smith","year":"1996","unstructured":"Smith M, Arthur D, Camitta B, Carroll AJ, Crist W, Gaynon P, Gelber R, Heerema N, Korn EL, Link M, Murphy S, Pui C-H, Pullen J, Reaman G, Sallan SE, Sather H, Shuster J, Simon R, Trigg M, Tubergen D, Uckun F, Ungerleider R . Uniform approach to risk classification and treatment assignment for children with acute lymphoblastic leukemia J Clin Oncol 1996 14: 18\u201324","journal-title":"J Clin Oncol"},{"key":"BF2401938_CR18","first-page":"483a","volume":"92","author":"LB Silverman","year":"1998","unstructured":"Silverman LB, Gelbert RD, Kimball-Dalton V, Young ML, Sallan SE . Results of the Dana-Farber Cancer Institute (DFCI) consortium protocol 91\u201301 for children with acute lymphoblastic leukemia (ALL) Blood 1998 92: (Suppl. 1) 483a","journal-title":"Blood"},{"key":"BF2401938_CR19","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.1056\/NEJM199806043382304","volume":"338","author":"JB Nachman","year":"1998","unstructured":"Nachman JB, Sather HN, Sensel MG, Trigg ME, Cherlow JM, Lukens JN, Wolff L, Uckun FM, Gaynon PS . Augmented post-induction therapy for children with high-risk acute lymphoblastic leukemia and a slow response to initial therapy New Engl J Med 1998 338: 1663\u20131671","journal-title":"New Engl J Med"},{"key":"BF2401938_CR20","first-page":"3310","volume":"95","author":"M Schrappe","year":"2000","unstructured":"Schrappe M, Reiter A, Ludwig W-D, Harbott J, Zimmermann M, Hiddemann W, Niemeyer C, Henze G, Feldges A, Zintl F, Kornhuber B, Ritter J, Welte K, Gadner H, Riehm H . Improved outcome in childhood acute lymphoblastic leukemia despite reduced use of anthracyclines and cranial radiotherapy: results of trial ALL-BFM 90 Blood 2000 95: 3310\u20133322","journal-title":"Blood"},{"key":"BF2401938_CR21","doi-asserted-by":"publisher","first-page":"2285","DOI":"10.1002\/(SICI)1097-0142(19971215)80:12<2285::AID-CNCR10>3.0.CO;2-Q","volume":"80","author":"LB Silverman","year":"1997","unstructured":"Silverman LB, McLean TW, Gelber RD, Donnelly MJ, Gilliland DG, Tarbell NJ, Sallan SE . Intensified therapy for infants with acute lymphoblastic leukemia: results from the Dana-Farber Cancer Institute Consortium Cancer 1997 80: 2285\u20132295","journal-title":"Cancer"},{"key":"BF2401938_CR22","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1056\/NEJM200004063421402","volume":"342","author":"M Aric\u00f2","year":"2000","unstructured":"Aric\u00f2 M, Valsecchi MG, Camitta B, Schrappe M, Chessells J, Baruchel A, Gaynon P, Silverman L, Janka-Schaub G, Kamps W, Pui C-H, Masera G . Outcome of treatment in children with Philadelphia chromosome-positive acute lymphoblastic leukemia New Engl J Med 2000 342: 998\u20131006","journal-title":"New Engl J Med"},{"key":"BF2401938_CR23","first-page":"697a","volume":"94","author":"BJ Druker","year":"1999","unstructured":"Druker BJ, Kantarjian H, Sawyers CL, Resta D, Reese SF, Ford J, Talpaz M . Activity of an ABL specific tyrosine kinase inhibitor in patients with BCR-ABL positive acute leukemias, including chronic myelogenous leukemia in blast crisis Blood 1999 94: (Suppl. 1) 697a","journal-title":"Blood"},{"key":"BF2401938_CR24","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1055\/s-2008-1026781","volume":"199","author":"H Riehm","year":"1987","unstructured":"Riehm H, Reiter A, Schrappe M, Berthold F, Dopfer R, Gerein H, Ludwig R, Ritter J, Stollmann B, Henze G . Die Corticosteroid-abh\u00e4ngige Dezimierung der Luek\u00e4miezellzahl im Blut als Prognosefaktor bei der akuten lymphoblastischen Leuk\u00e4mie im Kindesalter (Therpiestudie ALL-BFM 83) (The in vivo response on corticosteroid therapy as an additional prognostic factor in childhood acute lymphoblastic leukemia (therapy study ALL-BFM 83)) Klin P\u00e4diatr 1987 199: 151\u2013160","journal-title":"Klin P\u00e4diatr"},{"key":"BF2401938_CR25","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1002\/(SICI)1097-0142(19971101)80:9<1717::AID-CNCR4>3.0.CO;2-B","volume":"80","author":"PS Gaynon","year":"1997","unstructured":"Gaynon PS, Desai AA, Bostrom BC, Hutchinson RJ, Lange BJ, Nachman JB, Reaman GH, Sather HN, Steinherz PG, Trigg ME, Tubergen DG, Uckun FM . Early response to therapy and outcome in childhood acute lymphoblastic leukemia. A review Cancer 1997 80: 1717\u20131726","journal-title":"Cancer"},{"key":"BF2401938_CR26","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1046\/j.1365-2141.1997.1002914.x","volume":"97","author":"JS Lilleyman","year":"1997","unstructured":"Lilleyman JS, Gibson BES, Stevens RF, Will AM, Hann IM, Richards SM, Hill FGH . Clearance of marrow infiltration after 1 week of therapy for childhood lymphoblastic leukaemia: clinical importance and the effect of daunorubicin Br J Haematol 1997 97: 603\u2013606","journal-title":"Br J Haematol"},{"key":"BF2401938_CR27","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.1182\/blood.V86.4.1292.bloodjournal8641292","volume":"86","author":"A Gajjar","year":"1995","unstructured":"Gajjar A, Ribeiro R, Hancock ML, Rivera GK, Mahmoud H, Sandlund JT, Crist WM, Pui C-H . Persistence of circulating blasts after 1 week of multiagent chemotherapy confers a poor prognosis in childhood acute lymphoblastic leukemia Blood 1995 86: 1292\u20131295","journal-title":"Blood"},{"key":"BF2401938_CR28","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1016\/S0140-6736(97)10295-1","volume":"351","author":"E Coustan-Smith","year":"1998","unstructured":"Coustan-Smith E, Behm FG, Sanchez J, Boyett JM, Hancock ML, Raimondi SC, Rubnitz JE, Rivera GK, Sandlund JT, Pui C-H, Campana D . Immunological detection of minimal residual disease in children with acute lymphoblastic leukaemia Lancet 1998 351: 550\u2013554","journal-title":"Lancet"},{"key":"BF2401938_CR29","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1056\/NEJM199808273390904","volume":"339","author":"H Cav\u00e9","year":"1998","unstructured":"Cav\u00e9 H, van der Werff ten Bosch J, Suciu S, Guidal C, Waterkeyn C, Otten J, Bakkus M, Thielemans K, Grandchamp B, Vilmer E . Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia New Engl J Med 1998 339: 591\u2013598","journal-title":"New Engl J Med"},{"key":"BF2401938_CR30","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.1016\/S0140-6736(98)04058-6","volume":"352","author":"JJM Van Dongen","year":"1998","unstructured":"Van Dongen JJM, Seriu T, Panzer-Gr\u00fcmayer ER, Biondi A, Pongers-Willemse MJ, Corral L, Stolz F, Schrappe M, Masera G, Kamps WA, Gadner H, van Wering ER, Ludwig W-D, Basso G, de Bruijn MAC, Cazzaniga G, Hettinger K, van der Does-van den Berg A, Hop WCJ, Riehm H, Bartram CR . Prognostic value of minimal residual disease in acute lymphoblastic leukaemia in childhood Lancet 1998 352: 1731\u20131738","journal-title":"Lancet"},{"key":"BF2401938_CR31","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1038\/sj.leu.2401780","volume":"14","author":"C-H Pui","year":"2000","unstructured":"Pui C-H, Campana D . New definition of remission in childhood acute lymphoblastic leukemia Leukemia 2000 14: 783\u2013785","journal-title":"Leukemia"},{"key":"BF2401938_CR32","unstructured":"Coustan-Smith E, Sancho J, Hancock ML, Boyett JM, Behm FG, Raimondi SC, Sandlund JT, Rivera GK, Rubnitz JE, Ribeiro RC, Pui C-H, Campana D . Sequential monitoring of minimal residual disease in childhood acute lymphoblastic leukemia Blood (in press)"},{"key":"BF2401938_CR33","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1056\/NEJM199808273390907","volume":"339","author":"C-H Pui","year":"1998","unstructured":"Pui C-H, Evans WE . Drug therapy. Acute lymphoblastic leukemia New Engl J Med 1998 339: 605\u2013615","journal-title":"New Engl J Med"},{"key":"BF2401938_CR34","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1056\/NEJM199307293290504","volume":"329","author":"HH Mahmoud","year":"1993","unstructured":"Mahmoud HH, Rivera GK, Hancock ML, Krance RA, Kun LE, Behm FG, Ribeiro RC, Sandlund JT, Crist WM, Pui C-H . Low leukocyte counts with blast cells in cerebrospinal fluid of children with newly diagnosed acute lymphoblastic leukemia New Engl J Med 1993 329: 314\u2013319","journal-title":"New Engl J Med"},{"key":"BF2401938_CR35","unstructured":"Gajjar A, Harrison PL, Sandlund JT, Rivera GK, Ribeiro R, Rubnitz J, Relling M, Evans W, Boyett JM, Pui C-H . Traumatic lumbar puncture at diagnosis adversely affects outcome in childhood acute lymphoblastic leukemia Blood (in press)"},{"key":"BF2401938_CR36","doi-asserted-by":"publisher","first-page":"2817","DOI":"10.1182\/blood.V93.9.2817","volume":"93","author":"MV Relling","year":"1999","unstructured":"Relling MV, Hancock ML, Boyett JM, Pui C-H, Evans WE . Prognostic importance of 6-mercaptopurine dose intensity in acute lymphoblastic leukemia Blood 1999 93: 2817\u20132823","journal-title":"Blood"},{"key":"BF2401938_CR37","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1046\/j.1365-2141.2000.01843.x","volume":"109","author":"C-H Pui","year":"2000","unstructured":"Pui C-H, Relling MV . Topoisomerase II inhibitor-related acute myeloid leukemia Br J Haematol 2000 109: 13\u201323","journal-title":"Br J Haematol"},{"key":"BF2401938_CR38","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1038\/sj.leu.2400928","volume":"12","author":"MV Relling","year":"1998","unstructured":"Relling MV, Yanishevski Y, Nemec J, Evans WE, Boyett JM, Behm FG, Pui C-H . Etoposide and antimetabolite pharmacology in patients who develop secondary acute myeloid leukemia Leukemia 1998 12: 346\u2013352","journal-title":"Leukemia"},{"key":"BF2401938_CR39","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/S0140-6736(98)11079-6","volume":"354","author":"MV Relling","year":"1999","unstructured":"Relling MV, Rubnitz JE, Rivera GK, Boyett JM, Hancock ML, Felix CA, Kun LE, Walter AW, Evans WE, Pui C-H . High incidence of secondary brain tumours after radiotherapy and antimetabolites Lancet 1999 354: 34\u201339","journal-title":"Lancet"},{"key":"BF2401938_CR40","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1126\/science.286.5439.487","volume":"286","author":"WE Evans","year":"1999","unstructured":"Evans WE, Relling MV . Pharmacogenomics: translating functional genomics into rational therapeutics Science 1999 286: 487\u2013491","journal-title":"Science"},{"key":"BF2401938_CR41","first-page":"1680","volume":"9","author":"C-H Pui","year":"1995","unstructured":"Pui C-H, Relling MV, Behm FG, Hancock ML, Boyett JM, Raimondi SC, Krance RA, Mahmoud HH, Ribeiro RC, Sandlund JT, Head DR, Evans WE, Crist WM, Rivera GK . L-asparaginase may potentiate the leukemogenic effect of the epipodophyllotoxins Leukemia 1995 9: 1680\u20131684","journal-title":"Leukemia"}],"container-title":["Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/2401938.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/2401938","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/2401938.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T17:38:05Z","timestamp":1648748285000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/2401938"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,12,1]]},"references-count":41,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2000,12,1]]}},"alternative-id":["BF2401938"],"URL":"https:\/\/doi.org\/10.1038\/sj.leu.2401938","relation":{},"ISSN":["0887-6924","1476-5551"],"issn-type":[{"value":"0887-6924","type":"print"},{"value":"1476-5551","type":"electronic"}],"subject":[],"published":{"date-parts":[[2000,12,1]]},"assertion":[{"value":"30 May 2000","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 August 2000","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 December 2000","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}